Scientists have created the first new anti-malaria drug in quarter of a century in a bid to cut out resistance to existing treatments. Researchers found their new treatment has a “very high cure rate” ...

Advances in vaccine technology, antibody therapies, and genetic surveillance are giving researchers new tools to fight ...

Every year, malaria kills more than 600,000 people worldwide. Most of them are children under 5 in sub-Saharan Africa. But ...

Brazilian researchers have developed a synthetic compound that has the potential to treat malaria and block its transmission.

Add Yahoo as a preferred source to see more of our stories on Google. This October 2024 image provided by Novartis shows GanLum, a new anti-malaria treatment, at a manufacturing facility in Slovenia. ...

A clinical trial by Menzies School of Health Research (Menzies) published in The Lancet has revealed promising results to reduce malaria relapses, through the broader use of primaquine. Primaquine is ...

Malaria is a life-threatening disease that is transferred by mosquito bites. Interestingly, a specific type of mosquito can carry the disease. The transfer of the parasite to humans travels to the ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...

Artesunate AMIVAS is now available for purchase across Europe and U.K. through Nordic Prime of Denmark. Artesunate AMIVAS, approved by EU Commission and U.K.’s Medicine and Healthcare Product ...

Explore the challenges and progress of the Asia-Pacific region in achieving malaria elimination by 2030 amidst funding issues and treatment resistance.

NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...